Molecular heterogeneity and prognostic biomarkers in adults with acute myeloid leukemia and normal cytogenetics : Myeloid diseaseMARCUCCI, Guido; MROZEK, Krzysztof; BLOOMFIELD, Clara D et al.Current opinion in hematology. 2005, Vol 12, Num 1, pp 68-75, issn 1065-6251, 8 p.Article

Molecular and clinical advances in core binding factor primary acute myeloid leukemia : A paradigm for translational research in malignant hematologyMARCUCCI, Guido; CALIGIURI, Michael A; BLOOMFIELD, Clara D et al.Cancer investigation. 2000, Vol 18, Num 8, pp 768-780, issn 0735-7907Article

Epigenetics in Acute Myeloid LeukemiaPLASS, Christoph; OAKES, Christopher; BLUM, William et al.Seminars in oncology. 2008, Vol 35, Num 4, pp 378-387, issn 0093-7754, 10 p.Article

Determination of cellular uptake and intracellular levels of Cenersen (Aezea^®, EL625), a p53 antisense oligonucleotide in acute myeloid leukemia cellsALACHKAR, Houda; ZHILIANG XIE; MARCUCCI, Guido et al.Journal of pharmaceutical and biomedical analysis. 2012, Vol 71, pp 228-232, issn 0731-7085, 5 p.Article

Clinical outcome of de novo acute myeloid leukaemia patients with normal cytogenetics is affected by molecular genetic alterations : a concise reviewBALDUS, Claudia D; MROZEK, Krzysztof; MARCUCCI, Guido et al.British journal of haematology. 2007, Vol 137, Num 5, pp 387-400, issn 0007-1048, 14 p.Article

The prognostic and functional role of microRNAs in acute myeloid leukemiaMARCUCCI, Guido; MROZEK, Krzysztof; RADMACHER, Michael D et al.Blood. 2011, Vol 117, Num 4, pp 1121-1129, issn 0006-4971, 9 p.Article

Prognostic Implications of Gene Mutations in Acute Myeloid Leukemia With Normal CytogeneticsGAIDZIK, Verena; DÖHNER, Konstanze.Seminars in oncology. 2008, Vol 35, Num 4, pp 346-355, issn 0093-7754, 10 p.Article

Gene Expression With Prognostic Implications in Cytogenetically Normal Acute Myeloid LeukemiaBALDUS, Claudia D; BULLINGER, Lars.Seminars in oncology. 2008, Vol 35, Num 4, pp 356-364, issn 0093-7754, 9 p.Article

Core Binding Factor Acute Myeloid LeukemiaPASCHKA, Peter.Seminars in oncology. 2008, Vol 35, Num 4, pp 410-417, issn 0093-7754, 8 p.Article

Allogeneic Stem Cell Transplantation in Acute Myeloid Leukemia in First or Subsequent Remission : Weighing Prognostic Markers Predicting Relapse and Risk Factors for Non-relapse MortalityMEIJER, Ellen; CORNELISSEN, Jan J.Seminars in oncology. 2008, Vol 35, Num 4, pp 449-457, issn 0093-7754, 9 p.Article

Molecular Genetics of Adult Acute Myeloid Leukemia: Prognostic and Therapeutic ImplicationsMARCUCCI, Guido; HAFERLACH, Torsten; DÖHNER, Hartmut et al.Journal of clinical oncology. 2011, Vol 29, Num 5, pp 475-486, issn 0732-183X, 12 p.Article

Clinical relevance of mutations and gene-expression changes in adult acute myeloid leukemia with normal cytogenetics : are we ready for a prognostically prioritized molecular classification?MROZEK, Krzysztof; MARCUCCI, Guido; PASCHKA, Peter et al.Blood. 2007, Vol 109, Num 2, pp 431-448, issn 0006-4971, 18 p.Article

Genetic Validation of the Protein Arginine Methyltransferase PRMT5 as a Candidate Therapeutic Target in GlioblastomaFENGTING YAN; ALINARI, Lapo; JACOB, Naduparambil K et al.Cancer research (Chicago, Ill.). 2014, Vol 74, Num 6, pp 1752-1765, issn 0008-5472, 14 p.Article

Identification of a 24-Gene Prognostic Signature That Improves the European LeukemiaNet Risk Classification of Acute Myeloid Leukemia: An International Collaborative StudyZEJUAN LI; HEROLD, Tobias; XINAN YANG et al.Journal of clinical oncology. 2013, Vol 31, Num 9, pp 1172-1181, issn 0732-183X, 10 p.Article

Sphingosine kinase-1 and sphingosine 1-phosphate receptor 2 mediate Bcr-Abl1 stability and drug resistance by modulation of protein phosphatase 2ASALAS, Arelis; PONNUSAMY, Suriyan; OBEID, Lina M et al.Blood. 2011, Vol 117, Num 22, pp 5941-5952, issn 0006-4971, 12 p.Article

ASXL1 mutations identify a high-risk subgroup of older patients with primary cytogenetically normal AML, within the ELN Favorable genetic categoryMETZELER, Klaus H; BECKER, Heiko; POWELL, Bayard L et al.Blood. 2011, Vol 118, Num 26, pp 6920-6929, issn 0006-4971, 10 p.Article

Delivery of antisense oligodeoxyribonucleotide lipopolyplex nanoparticles assembled by microfluidic hydrodynamic focusingGUAN KOH, Chee; XULANG ZHANG; CHAN, Kenneth K et al.Journal of controlled release. 2010, Vol 141, Num 1, pp 62-69, issn 0168-3659, 8 p.Article

Mutations of the Wilms tumor 1 gene (WT1) in older patients with primary cytogenetically normal acute myeloid leukemia: a Cancer and Leukemia Group B studyBECKER, Heiko; MARCUCCI, Guido; WU, Yue-Zhong et al.Blood. 2010, Vol 116, Num 5, pp 788-792, issn 0006-4971, 5 p.Article

A Novel Raji-Burkitt's Lymphoma Model for Preclinical and Mechanistic Evaluation of CD52-Targeted Immunotherapeutic AgentsLAPALOMBELLA, Rosa; XIAOBIN ZHAO; LEE, L. James et al.Clinical cancer research. 2008, Vol 14, Num 2, pp 569-578, issn 1078-0432, 10 p.Article

Adverse prognostic significance of KIT mutations in adult acute myeloid leukemia with inv(16) and t(8;21) : A cancer and leukemia group B studyPASCHKA, Peter; MARCUCCI, Guido; KOLITZ, Jonathan E et al.Journal of clinical oncology. 2006, Vol 24, Num 24, pp 3904-3911, issn 0732-183X, 8 p.Article

A phase 1 and pharmacodynamic study of depsipeptide (FK228) in chronic lymphocytic leukemia and acute myeloid leukemiaBYRD, John C; MARCUCCI, Guido; LUCAS, David M et al.Blood. 2005, Vol 105, Num 3, pp 959-967, issn 0006-4971, 9 p.Article

Differential expression of histone post-translational modifications in acute myeloid and chronic lymphocytic leukemia determined by high-pressure liquid chromatography and mass spectrometryLIWEN ZHANG; FREITAS, Michael A; WICKHAM, Joseph et al.Journal of the American Society for Mass Spectrometry. 2004, Vol 15, Num 1, pp 77-86, issn 1044-0305, 10 p.Article

The partial nontandem duplication of the MLL (ALL1) gene is a novel rearrangement that generates three distinct fusion transcripts in B-cell acute lymphoblastic leukemiaWHITMAN, Susan P; STROUT, Matthew P; CALIGIURI, Michael A et al.Cancer research (Baltimore). 2001, Vol 61, Num 1, pp 59-63, issn 0008-5472Article

Low dose decitabine in very high risk relapsed or refractory acute myeloid leukaemia in children and young adultsPHILLIPS, Christine L; DAVIES, Stella M; BLUM, William et al.British journal of haematology. 2013, Vol 161, Num 3, pp 406-410, issn 0007-1048, 5 p.Article

Genome-wide methylation profiling in decitabine-treated patients with acute myeloid leukemiaYAN, Pearily; FRANKHOUSER, David; METZELER, Klaus et al.Blood. 2012, Vol 120, Num 12, pp 2466-2474, issn 0006-4971, 9 p.Article